Skip to content

Transformation and Achievement: The Five-Year Journey of Wilmot Toward the Prestigious 'Blue Ribbon' Award

Wilmot Cancer Institute reached a milestone set five years prior: Applying for the National Cancer Institute's P30 Cancer Center Support Grant (CCSG) in September 2021. In this interview, Wilmot Cancer Institute's Director, Jonathan Friedberg, M.D., M.M.Sc., shares his insights on the...

Exploration and Achievement: Wilmot's Half-Decade Path to the prestigious 'Blue Ribbon' Award
Exploration and Achievement: Wilmot's Half-Decade Path to the prestigious 'Blue Ribbon' Award

Transformation and Achievement: The Five-Year Journey of Wilmot Toward the Prestigious 'Blue Ribbon' Award

The Wilmot Cancer Institute has been making significant strides in its mission to combat cancer, with a focus on team science and strategic recruitment. Over the past five years, a recruitment drive has brought in more than 20 top-flight physicians and scientists to the Institute.

To further strengthen its research capabilities, the Institute has assembled three broad research programs, five shared resource programs, and gathered 100 scientific members and executives. This collaborative approach aims to foster innovation and advance cancer research.

In addition to its research focus, the Institute has also prioritised community engagement. A Community Outreach and Engagement office has been created, connecting patient needs with physicians and scientists. This office is instrumental in addressing disparities and ensuring that the Institute's research and care are accessible to all.

The Wilmot Cancer Institute has set a goal to apply for a P30 Cancer Center Support Grant (CCSG) from the National Cancer Institute (NCI) in 2021. The grant application process involved restructuring the cancer center, millions of dollars in investment, and herculean efforts. The 1,100-page grant was uploaded to the NCI in September 2021, and the review process is underway with a decision expected in the summer.

If awarded, the grant would place Wilmot Cancer Institute among 71 NCI-designated cancer centers in the U.S. The NCI designation is considered the blue ribbon for cancer centers and requires renewal every five years. It comes with research grants, salary support, new equipment, support for clinical trials, and education.

While the decision on the grant is pending, the Institute has made significant improvements in understanding the region's cancer burden, forming new research collaborations, increasing clinical trials efforts, and establishing community outreach and education programs. If not designated in 2022, the Institute has demonstrated its commitment to continuous improvement and progress.

The Clinical Trials Office has been restructured, resulting in a 70% increase in patient participation in trials. This focus on clinical trials reflects the Institute's commitment to bringing innovative treatments to patients as quickly and safely as possible.

A new education and training program has been built, serving high school students to junior faculty and emphasising diversity. This programme is a testament to the Institute's commitment to nurturing the next generation of cancer researchers and healthcare providers.

The Institute has also defined a 27-county "catchment area" for patient care and research, encompassing 3 million residents who seek care at Wilmot. To better serve this community, an informatics team and data-mapping tool for cancer hotspots have been built.

In the meantime, patients continue to prefer treatment at an NCI-designated center due to the interaction between physicians and scientists and the top doctors wanting to work there. The Institute's ongoing efforts and improvements are a testament to its dedication to providing the best possible care and research in the fight against cancer.

Notably, Baylor College of Medicine also applied for the P30 Cancer Center Support Grant from the NCI in September 2021. This is indicated by their receipt of the grant (NCI-CA125123) supporting bladder cancer research there. Only a few new cancer centers have received the top NCI designation over the last decade, making the competition fierce.

As the decision on the grant approaches, the Wilmot Cancer Institute remains hopeful and focused on its mission to conquer cancer. Whether designated in 2022 or not, the Institute's commitment to research, education, and community engagement is unwavering.

Read also:

Latest